Mohd. Wasiullah,
Piyush Yadav,
Satish Kumar Yadav,
Ratnesh Yadav,
- Principal, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
- Academic Head, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
- Associate Professor, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
- Scholar, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
Abstract
This detailed article review examines innovations in pediatric drug formulation, highlighting developments that cater to children’s specific healthcare needs. It covers pediatric pharmacology and advanced solutions like nanoparticle drug delivery and taste-making techniques, focusing on improving the safety, effectiveness, and acceptability of medications for young patients. The review highlights the benefits for patients, including improved adherence to treatment, fewer side effects, and better overall treatment outcomes. It also addresses regulatory and ethical issues, emphasizing the need for a careful balance between scientific advancements and ethical responsibilities. The conclusion envisions a future with precision medicine and personalized formulations while recognizing. The challenges ahead for pediatric healthcare. It includes novel dosage forms designed for children, like oral liquids, orally disintegrating tablets, and chewable options, as well as advancements in taste-masking technologies to improve medication palatability. The review also emphasizes age-appropriate dosing, personalized medicine strategies, and user-friendly administration devices.
Keywords: Drug Formulation, Pediatric Pharmacology, Nanoparticles, Patient Compliance, , Regulatory Compliance
[This article belongs to International Journal of Biochemistry and Biomolecule Research ]
Mohd. Wasiullah, Piyush Yadav, Satish Kumar Yadav, Ratnesh Yadav. Innovative Approaches in Pediatric Drug Formulation Catering to Specialized Need: Review Article. International Journal of Biochemistry and Biomolecule Research. 2025; 03(01):35-43.
Mohd. Wasiullah, Piyush Yadav, Satish Kumar Yadav, Ratnesh Yadav. Innovative Approaches in Pediatric Drug Formulation Catering to Specialized Need: Review Article. International Journal of Biochemistry and Biomolecule Research. 2025; 03(01):35-43. Available from: https://journals.stmjournals.com/ijbbr/article=2025/view=198202
References
1. Rakhmanina NY, van den Anker JN. Pharmacological research in pediatrics: From neonates to adolescents. Adv Drug Deliv Rev. 2006 Apr 20;58(1):4–14.
2. Green DJ, Zineh I, Burckart GJ. Pediatric drug development: outlook for science‐based innovation. Clin Pharmacol Therapeut. 2018;103(3):376–378.
3. Smyth RL, Edwards AD. A major new initiative to improve treatment for children. Arch Dis Childhood. 2006;91(3):212–213.
4. Holford N, Heo YA, Anderson B. A pharmacokinetic standard for babies and adults. J Pharma Sci. 2013;102(9):2941–2952.
5. Bartelink IH, Rademaker CM, Schobben AF, Van Den Anker JN. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmaco. 2006;45:1077–1097.
6. Cohen-Wolkowiez M, Moran C, Benjamin Jr DK, Smith PB. Pediatric antifungal agents. Curr Opin Infect Diseases. 2009;22(6):553–558.
7. Lu H, Rosenbaum S. Developmental pharmacokinetics in pediatric populations. J Pediatr Pharmacol Therapeut. 2014;19(4):262–276.
8. Touw DJ, Graafland O, Cranendonk A, Vermeulen RJ, Van Weissenbruch MM. Clinical pharmacokinetics of phenobarbital in neonates. Euro J Pharma Sci. 2000;12(2):111–116.
9. Breitkreutz J, Boos J. Paediatric and geriatric drug delivery. Expert Opin Drug Deliv. 2007;4(1):37–45.
10. Alcorn J, mcnamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants part I. Clin Pharmaco. 2002;41:959–998.
11. Silverio J, Poole JW. Serum concentrations of ampicillin in newborn infants after oral administration. Pediatrics. 1973;51(3):578–580.
12. Bodé S, Dreyer M, Greisen G. Gastric emptying and small intestinal transit time in preterm infants: a scintigraphic method. J Pediatr Gastroenterol Nutr. 2004;39(4):378–382.
13. Strolin Benedetti M, Baltes EL. Drug metabolism and disposition in children. Fundament Clin Pharmacol. 2003;17(3):281–299.
14. Rakhmanina NY, van den Anker JN. Pharmacological research in pediatrics: from neonates to adolescents. Adv Drug Deliv Rev. 2006;58(1):4–14.
15. Gosden PE, Bedford KA, Dixon JJ, Speidel BD, Leaf AA, Macgowan AP. Pharmacokinetics of once-a-day netilmicin (4.5 mg/kg) in neonates. J Chemother. 2001;13(3):270–276.
16. Ramezani AM, Shayanfar A, Manzoori JL, Jouyban A. Solubility of some basic drugs in dioxane+ water mixtures at 298.2 K. Latin American J Pharm. 2012;31(8):1176–1181.
17. Millard JW, Alvarez-Nunez FA, Yalkowsky SH. Solubilization by cosolvents: Establishing useful constants for the log–linear model. Int J Pharm. 2002;245(1-2):153–166.
18. Vignesh M, Sivakumar M, Parkavi V, Selvakumar K, Joysa Ruby J. Stabilization of folic acid in liquid dosage form: formulation development, method validation and comparative analysis. Int J Pharm Chem Sci. 2012;1:332–338.
19. Ali AA, Charoo NA, Abdallah DB. Pediatric drug development: formulation considerations. Drug Devel Ind Pharm. 2014;40(10):1283–1299.
20. Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. New Eng J Med. 2006;354(16):1698–1705.
21. Reddy LH, Ghosh B. Fast dissolving drug delivery systems: A review of the literature. Indian J Pharm Sci. 2002;64(4):331–336.
22. Aurora J, Pathak V. Oral disintegrating technologies: Oral disintegrating dosage forms: An overview. Drug Deliv Technol. 2005;5(3):50–54.
| Volume | 03 |
| Issue | 01 |
| Received | 14/12/2024 |
| Accepted | 07/01/2025 |
| Published | 13/02/2025 |
| Publication Time | 61 Days |
Login
PlumX Metrics